Business Wire

CA-VERIMATRIX

18.3.2024 17:46:33 CET | Business Wire | Press release

Share
Verimatrix Releases Counterspy as a New Anti-Piracy Solution with First-Ever Defensive Capabilities

Regulatory News:

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced general availability of its new Verimatrix Counterspy anti-piracy solution -- the most advanced anti-piracy technology seen in the past decade.

Counterspy leverages technology first developed by the company's cybersecurity team back in 2021 to offer an innovative new way to counter the rise in video piracy in an era where streaming apps are prevalent. Counterspy is a standalone product within Verimatrix's anti-piracy team, engineered to prevent video content theft, shield apps from attack, and provide ongoing piracy threat prediction, detection and response services.

Counterspy goes beyond traditional methods to ensure top-tier security for media app subscribers, safeguarding content across various devices. It fills the gap in authentication created by the shift from operator-controlled set top box hardware to retail or app-based OTT clients, allowing operators to distribute content confidently while preventing piracy. With Counterspy, each app instance is authenticated and tied to a specific subscriber, ensuring transparency and control over access. By safeguarding the authentication token from theft or manipulation, Counterspy prevents abuse and ensures legitimate access to content, going above and beyond traditional DRM vendors.

What makes Counterspy stand out:

  • Unique Protection and Threat Detection from the Video Service Provider to the Consumer Device: Verimatrix Counterspy effortlessly brings security into the unmanaged consumer device via the video app, something that has been lacking since the explosion of OTT streaming services that use consumers’ own devices. Verimatrix combined the best of its anti-piracy technologies with its cybersecurity innovations to create a bold new approach to tackling the piracy problem – a breakthrough leap forward.
  • AI/ML-Driven Real-Time Protection: Leveraging the latest in artificial intelligence and machine learning, Counterspy can quickly identify piracy signals and cybersecurity threats, allowing for the real-time deployment of countermeasures.
  • Multi-Layered Security Approach: Counterspy builds on proven technologies such as DRM and watermarking, with a new generation of sophisticated app protection and piracy monitoring tools to detect suspicious activity. This allows video service providers to pinpoint suspicious behavior at its source – as it’s happening – to thwart bad actors without impacting the experience of legitimate service subscribers. By shielding the app, Counterspy also protects personal information and payment card details belonging to video service subscribers. This multi-layered approach to video content + app security, along with the ability to deploy real-time anti-piracy countermeasures, allows streaming operators to continuously evolve their response to emerging threats – staying one step ahead of the pirates.

“With our release of Counterspy, Verimatrix is at the forefront of the innovation needed to fight today’s sophisticated pirates within a vastly connected content viewing ecosystem,” said Andrew Bear, head of anti-piracy business at Verimatrix. “Yesterday’s security approaches are no longer enough to protect both revenue and content. Counterspy enables streaming operators to immediately fight back against pirates that seek to use the latest and often unnoticed business-draining techniques. We see Counterspy as a giant leap forward for security in the M&E industry because it can be directly linked to millions of dollars in prevented piracy-related losses as well as notable operating cost savings.”

For operators, Counterspy targets piracy and revenue leakage, enhances content security and app protections, and helps prevent the compromise of user data. A Verimatrix telco customer who deployed an early release version of Counterspy realized an OPEX savings of $300,000, and they prevented direct piracy losses of $21 million in one year. Counterspy's design for speedy and straightforward integration into streaming video clients allows operators to detect and efficiently counteract piracy directly at its source – serving as an "autonomous security solution" that stands in stark contrast to traditional methods.

Counterspy is part of the Verimatrix Streamkeeper suite of security solutions and can be flexibly deployed alongside other Verimatrix technologies, including Multi-DRM and Watermarking. Operators can schedule a demo by clicking here.

A live webinar is scheduled to take place on March 19 at 5 p.m. CET / 9 a.m. PST with security experts from Verimatrix and sports leader beIN discussing piracy in today’s video ecosystem and showing why a combination of classic video protection and cybersecurity is key for success. Presenters include Lee Kent from beIN, Klaus Schenk, SVP Security and Threat Research at Verimatrix, and Maria Malinkowitsch, VP Video Protection Business at Verimatrix. Register here.

A companion white paper has also been made available for download, "Securing the Streaming Seas: Verimatrix Counterspy's Superior Defense Against Piracy In a World Dominated by Video Apps."

About Verimatrix
Verimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports, to sensitive financial and healthcare data, to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240318045012/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye